Arcellx Inc (ACLX)
82.76
-1.38
(-1.64%)
USD |
NASDAQ |
Sep 27, 16:00
82.73
-0.03
(-0.04%)
After-Hours: 20:00
Arcellx Enterprise Value: 3.932B for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 3.932B |
| September 26, 2024 | 4.006B |
| September 25, 2024 | 4.031B |
| September 24, 2024 | 4.022B |
| September 23, 2024 | 4.105B |
| September 20, 2024 | 4.139B |
| September 19, 2024 | 4.076B |
| September 18, 2024 | 3.813B |
| September 17, 2024 | 3.676B |
| September 16, 2024 | 3.623B |
| September 13, 2024 | 3.617B |
| September 12, 2024 | 3.503B |
| September 11, 2024 | 3.483B |
| September 10, 2024 | 3.471B |
| September 09, 2024 | 3.476B |
| September 06, 2024 | 3.313B |
| September 05, 2024 | 3.266B |
| September 04, 2024 | 3.002B |
| September 03, 2024 | 3.038B |
| August 30, 2024 | 3.178B |
| August 29, 2024 | 3.111B |
| August 28, 2024 | 3.209B |
| August 27, 2024 | 3.325B |
| August 26, 2024 | 3.348B |
| August 23, 2024 | 3.213B |
| Date | Value |
|---|---|
| August 22, 2024 | 3.056B |
| August 21, 2024 | 3.066B |
| August 20, 2024 | 3.025B |
| August 19, 2024 | 3.051B |
| August 16, 2024 | 2.992B |
| August 15, 2024 | 2.970B |
| August 14, 2024 | 2.723B |
| August 13, 2024 | 2.743B |
| August 12, 2024 | 2.652B |
| August 09, 2024 | 2.658B |
| August 08, 2024 | 2.310B |
| August 07, 2024 | 2.220B |
| August 06, 2024 | 2.264B |
| August 05, 2024 | 2.230B |
| August 02, 2024 | 2.457B |
| August 01, 2024 | 2.629B |
| July 31, 2024 | 2.798B |
| July 30, 2024 | 2.791B |
| July 29, 2024 | 2.814B |
| July 26, 2024 | 2.938B |
| July 25, 2024 | 2.845B |
| July 24, 2024 | 2.814B |
| July 23, 2024 | 2.871B |
| July 22, 2024 | 2.860B |
| July 19, 2024 | 2.838B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
46.73M
Minimum
May 18 2022
4.139B
Maximum
Sep 20 2024
1.433B
Average
1.175B
Median
Aug 08 2023
Enterprise Value Benchmarks
| Johnson & Johnson | 404.55B |
| NovaBay Pharmaceuticals Inc | 3.420M |
| Palatin Technologies Inc | 6.268M |
| iBio Inc | 4.741M |
| Theriva Biologics Inc | -13.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.20M |
| Revenue (Quarterly) | 27.38M |
| Total Expenses (Quarterly) | 62.38M |
| EPS Diluted (Quarterly) | -0.51 |
| Profit Margin (Quarterly) | -99.34% |
| Earnings Yield | -1.26% |
| Normalized Earnings Yield | -1.257 |